Traditional forms of treatment - tablets and oral suspension – are not used in patients with angle-closure glaucoma or with narrow anterior chamber angles. oxyOxybutynin is not used in patients with myasthenia gravis, non-persistent cardiovascular status in acute hemorrhage. These two forms of the medicine are also contraindicated in patients with obstructive uropathy, obstruction of the gastrointestinal tract, paralytic ileus, intestinal atony (in attenuated patients), megacolon, toxic megacolon complicating ulcerative colitis, or severe colitis. Oxybutynin extended-release tablets and transdermal system are not used in patients with: •    Increased risk of urinary retention; •    Increased risk of gastric retention; •    Decreased gastrointestinal motility conditions; •    Uncontrolled angle-closure glaucoma. Oxybutynin in all dosage forms is not used in patients with allergic reactions or known hypersensitivity to oxybutynin or any ingredient in the formulations.

Related Posts

Oxybutynin uses thumbnail

Oxybutynin uses

The medicines containing Oxybutynin as the main component are indicated to treat: overactive bladder symptoms and primary nocturnal enuresis in children. Oxybutynin effectively manages the symptoms
Oxybutynin medication thumbnail

Oxybutynin medication

Oxybutynin is a genitourinary antispasmodic medication, a synthetically made tertiary amine antimuscarinic agent. It is produced under the brand names Ditropan, Ditropan XL, Oxytrol, Gelnique,